|
HamHead
Hard Ass Motherfucker



Registered: 03/17/15
Posts: 6,107
Loc: Galactic sector ZZ9 Plura...
Last seen: 2 years, 8 months
|
Moderna - "We have to make a profit"
#26848728 - 07/27/20 08:11 PM (3 years, 5 months ago) |
|
|
https://finance.yahoo.com/news/moderna-ceo-credits-us-support-for-phase-3-vaccine-push-151225197.html
"Moderna CEO credits US support for Phase 3 vaccine push, says 'we have to make a profit' Anjalee Khemlani July 27, 2020, 9:12 am
Moderna (MRNA) CEO Stéphane Bancel partly credited the U.S. for the company’s rapid development of a COVID-19 vaccine candidate, telling Yahoo Finance on Monday it could not have participated in such a robust trial without the federal government’s support.
The U.S.’s leading coronavirus vaccine candidate — one of several companies that are part of Operation Warp Speed — entered Phase 3 trials Monday, with hopes of results by October or November. Bancel cited the additional $472 million— which brings total funding up to $955 million — as integral to accelerated push.
“At the time we were thinking of a trial of 10,000 participants,” Bancel said of the initial plan in April, adding that discussions with the government researchers resulted in settling on a 30,000 participant trial.
Over the weekend, the company announced an additional round of funding from Biomedical Advanced Research and Development Authority (BARDA), a department under the U.S. Health and Human Services Department (HHS).
Moderna announced the first patient was dosed in Georgia with 100 micrograms of the vaccine candidate early Monday, but uncertainty remains as the trajectory of the outbreak determines how an effective vaccine is monitored and studied.
As the coronavirus tightens its grip on the world, the stakes for Moderna — and a potential COVID-19 treatment — are high. Typically, the vaccine industry is not as profitable as therapies, and a treatment that falls short could be a devastating blow to a relatively young company.
Moderna, in partnership with European-based Lonza, is producing at-risk 500 million doses for the year, and scaling up to potentially reach 1 billion doses by 2021.
The mRNA vaccine technology the company is using has not yet been tested on the market, and production is more complex than traditional vaccines. The U.S. Food and Drug Administration has set a bar of 50% efficacy of any vaccine, and will have to determine the technology’s potential compared to traditional vaccines.
‘We have to make a profit’ If successful, a vaccine will actually be the 10-year-old company’s first product on the market. Despite significant taxpayer funding, as well as investors boosting its market capitalization to $29 billion, the biotech upstart will need to make a profit — and will consider that in its pricing, Bancel said.
Exactly how much a vaccine shot will cost, and who’ll ultimately cover it, remains a big sticking point in the process.
“We have to make a profit out of the first product [we sell],” Bancel told Yahoo Finance. “We have invested $2 billion of our shareholder capital since we started the company. We need to get a return. We are highly aware this is a pandemic and we need to be very responsible on how we price a product.”
The company has said they will use previous vaccine prices as a benchmark, and will be providing discounts during the pandemic phase.
In a separate issue, questions have been raised over the company’s executives selling stock after positive results from early trials. That pattern that has been seen in other newly-popular biotechs.
Bancel reiterated the sales were set up in December 2018 after the company went public, but declined to address when or if the plans had since been modified. The company is in a silent period prior to second quarter earnings on August 5.
“What I can tell you 99% of my wealth is tied up in Moderna stock, so I’m very aligned with any of our shareholders,” Bancel said. “I had more stock on June 13 than I had on January 1. If any investor is worried they are not aligned with me, they should look at the numbers.”"

Awful lot of faith in a companies very first product made available to market.
Something tells me, those 500 million doses will be sold, one way, or an other.
-------------------- The Italian researchers’ findings, published by the INT’s scientific magazine Tumori Journal, show 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020 had developed coronavirus antibodies well before February. https://www.reuters.com/article/us-health-coronavirus-italy-timing-idUSKBN27V0KF This online first version has been peer-reviewed, accepted and edited, but not formatted and finalized with corrections from authors and proofreaders https://www.icandecide.org/
|
nooneman


Registered: 04/24/09
Posts: 14,555
Loc: Utah
|
Re: Moderna - "We have to make a profit" [Re: HamHead]
#26848770 - 07/27/20 08:30 PM (3 years, 5 months ago) |
|
|
Greedy bastards, you know they'll be first to market, but it'll probably be expensive. I bet it'll be highly effective though, the results of their trials have been spectacular so far.
Edited by nooneman (07/27/20 08:31 PM)
|
HamHead
Hard Ass Motherfucker



Registered: 03/17/15
Posts: 6,107
Loc: Galactic sector ZZ9 Plura...
Last seen: 2 years, 8 months
|
Re: Moderna - "We have to make a profit" [Re: nooneman]
#26848790 - 07/27/20 08:43 PM (3 years, 5 months ago) |
|
|
-------------------- The Italian researchers’ findings, published by the INT’s scientific magazine Tumori Journal, show 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020 had developed coronavirus antibodies well before February. https://www.reuters.com/article/us-health-coronavirus-italy-timing-idUSKBN27V0KF This online first version has been peer-reviewed, accepted and edited, but not formatted and finalized with corrections from authors and proofreaders https://www.icandecide.org/
|
Ice9
3X Ban Lotto Champion



Registered: 03/20/14
Posts: 11,232
Loc: daterapeville,USA
Last seen: 11 minutes, 16 seconds
|
Re: Moderna - "We have to make a profit" [Re: HamHead]
#26848993 - 07/27/20 11:13 PM (3 years, 5 months ago) |
|
|
Interesting, the money is not in the vaccine for Moderna (that would simply be a means to recoup losses) but in mRNA technology which would be a pretty big breakthrough. Curious how it pans out.
-------------------- The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man. -- George Brenard Shaw
|
HamHead
Hard Ass Motherfucker



Registered: 03/17/15
Posts: 6,107
Loc: Galactic sector ZZ9 Plura...
Last seen: 2 years, 8 months
|
Re: Moderna - "We have to make a profit" [Re: Ice9]
#26852293 - 07/29/20 04:50 PM (3 years, 5 months ago) |
|
|
https://www.lawfirms.com/resources/environment/environment-health/cdc-members-own-more-50-patents-connected-vaccinations
CDC Members Own More Than 50 Patents Connected to Vaccinations
The CDC Immunization Safety Office is responsible for investigating the safety and effectiveness of all new vaccinations; once an investigation is considered complete, a recommendation is then made to the CDC’s Advisory Committee on Immunization Practices (ACIP) who then determines whether the new vaccine will be added to the current vaccination schedule. Members of the ACIP committee include physicians such as Dr. Paul Offit, who also serves as the chief of infectious diseases at the Children's Hospital of Philadelphia. Offit and other CDC members own numerous patents associated with vaccinations and regularly receive funding for their research work from the very same pharmaceutical companies who manufacturer vaccinations which are ultimately sold to the public. This situation creates an obvious conflict of interest, as members of the ACIP committee benefit financially every time a new vaccination is released to the market.
Members of the ACIP Committee Directly Influence Public Health Each of the 12 members of the CDC's ACIP Committee has a significant influence on the health of nearly every member of the American population. Because they are responsible for adding to and/or altering the national vaccine schedule, it is of critical importance that they remain objective and unbiased before determining whether a new vaccination is appropriate for use, particularly in the bodies of vulnerable young children. Unfortunately, a significant number of ACIP committee members receive direct financial returns when more vaccinations are added to the current schedule. Many own vaccination related patent(s) and/or stock shares of the pharmaceutical companies responsible for supplying new vaccines to the public. Others receive research grant money, funding for their academic departments, or payments for the oversight of vaccine safety trials.
A Long List of Patents Owned by ACIP and Other CDC Members The following is a partial list of some of the patents that are owned or shared by members of the CDC and/or ACIP committee, including Dr. Paul Offit:
"Nucleic acid vaccines for prevention of flavivirus infection" - This patent comes into play during the manufacturing process of vaccines for yellow fever, Zika, Dengue, West Nile virus and more. Various vaccination testing methods - When pharmaceutical companies need to test aspects of a new vaccine, they may utilize one of the CDC's patented testing methods including an artificial lung system for aerosol vaccines and a process that screens new vaccines for human rhinoviruses. Adjuvant patents - Adjuvants are components within vaccinations intended to create an intensified immune reaction; members of the ACIP own patents on adjuvants used specifically in vaccinations created for premature babies and full term newborns. Assays that assist vaccine development - During the vaccine development process, manufacturers will often observe biological samples for specific antibodies; the CDC owns a patent on an assay that facilitates this monitoring system. Vaccine quality control - patents on various aspects of quality control for vaccinations are utilized by pharmaceutical companies on a large scale once a new vaccine is actively distributed to the public. In total, 56 individual patents were found to be owned or shared by one or more members of the ACIP committee or other committees within the CDC.
Members Claim They are Unbiased When prompted with questions pertaining to their financial connections with pharmaceutical companies, most ACIP members claim they are able to remain unbiased despite the rewards they receive every time a new vaccination is recommended to the public. In numerous instances, vaccines released to the market are later removed after serious side effects are documented. The rotavirus vaccine was one such example; it was pulled from the market in 1999, a year after its initial approval. In 2001, the House Government Reform Committee found that four out of the eight ACIP members who voted to approve the vaccine had direct financial ties to one or more of the pharmaceutical companies who produced the vaccine for public use. Similar situations involving many other vaccinations have been independently documented over the course of nearly 20 years.
A Multi Billion Dollar Industry The vaccination industry currently generates $30 billion in profit each year, some of which reaches the hands of the very people who create the vaccine schedule. Despite concerns connecting vaccinations to the increase in autism and a host of other disorders, the number of recommended vaccines continues to grow each year. With a new federal administration interested in uncovering the dirty secrets hidden within alliances between CDC members and vaccine manufacturers, we may begin to see a wave of personal injury and wrongful death lawsuits related directly to unethical behaviors which have led to numerous unsafe vaccines being pushed on an unknowing public. If the National Vaccine Injury Compensation Program (NVICP) is amended or repealed, victims of vaccine damage will be legally permitted to file claims directly against vaccine manufacturers and members of the ACIP committee who often have had knowledge of vaccine risks yet continue to recommend their widespread use."
-------------------- The Italian researchers’ findings, published by the INT’s scientific magazine Tumori Journal, show 11.6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020 had developed coronavirus antibodies well before February. https://www.reuters.com/article/us-health-coronavirus-italy-timing-idUSKBN27V0KF This online first version has been peer-reviewed, accepted and edited, but not formatted and finalized with corrections from authors and proofreaders https://www.icandecide.org/
|
Ice9
3X Ban Lotto Champion



Registered: 03/20/14
Posts: 11,232
Loc: daterapeville,USA
Last seen: 11 minutes, 16 seconds
|
Re: Moderna - "We have to make a profit" [Re: HamHead]
#26852830 - 07/30/20 12:03 AM (3 years, 5 months ago) |
|
|
Moderna has never made a dollar. As a company being profitable is important. It takes approximately 2 billion dollars to bring a drug to market in the US. The one's we need to regulate are those that evergreen patents, which allows huge price increases, and people who buy low demand generics and cause they are the sole maker jack the price up.
Full disclosure: I work in the pharma industry.
-------------------- The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man. -- George Brenard Shaw
|
Patlal
You ask too many questions



Registered: 10/09/10
Posts: 44,797
Loc: Ottawa
Last seen: 2 hours, 32 minutes
|
Re: Moderna - "We have to make a profit" [Re: Ice9]
#26853239 - 07/30/20 10:01 AM (3 years, 5 months ago) |
|
|
I 100% support the fact that Moderna will make a profit.
--------------------
|
O_Dweeds
Humanitarian Magician


Registered: 09/27/14
Posts: 942
Loc: Molecular (Creating, Watc...
Last seen: 2 years, 11 months
|
Re: Moderna - "We have to make a profit" [Re: Patlal]
#26854071 - 07/30/20 05:31 PM (3 years, 5 months ago) |
|
|
I see much of this vaccine going hand-in-hand with the global population, as a whole, becoming much more aware that EVERYTHING we experience is created collectively in our minds. With the exponential increasing of our awareness, how much we all both create & change our reality, and the understanding of quantum mechanics we individually all posses the ability to change reality however we want.
And for those who have known this for a long time and used it to manipulate & control the majority this is a nightmare. The ones who, even if asked today, would laugh and deny all of this as ludicrous, but when behind closed doors worry that they no longer have an army of mindless drones to do all their bidding. Temporarily keeping themselves clean of negative Karmic repercussions only to be hit the hardest down the line.
-------------------- Oxygen. Water. Neil Young Our word "planet" comes from the Greek word planetes, meaning "wanderer." "There ain't no revolution, only evolution, but every time I'm in Georgia I eat a peach for peace." Gregg Allman
|
|